Ensuring equity in vascularized composite allotransplantation

By Laura L. Kimberly, Elie P. Ramly, and Eduardo D. Rodriguez Vascularized composite allotransplantation (VCA) can be considered the innovative cousin of solid organ transplantation. VCA is the transplantation of multiple tissues, such as skin, muscle, nerve, and bone as a functional unit. This includes facial, upper and lower extremity, uterine, penile and abdominal wall […]

Read More…

Medical ethics in the anthropocene – the health sector must divest from industries impacting planetary health

By Christian M. Schulz. The fifth mass extinction began 66 million years ago after an asteroid, measuring 10 kilometers in diameter, hit the peninsula of Yucatán. At the end of this huge loss of biodiversity, caused probably by ocean acidification, the most prominent victims were the dinosaurs. Currently, biodiversity is declining faster than at any […]

Read More…

Frauds and misconduct in scientific research: a harsh lesson from the pandemic

By Erik Boetto and Davide Golinelli. Frauds and misconduct have been common in the history of science. A well-known example is that of former-doctor A.J. Wakefield, who published a study in 1998 reporting the association between measles, mumps, and rubella vaccination and a syndrome of autism in children. Only in 2011 was it proven that […]

Read More…

Expanding insurance coverage for in vitro fertilization with pre-implantation genetic testing

By Madison K. Kilbride When prospective parents learn that they’re at risk of passing a genetic condition to their future children, they’re often very concerned. Currently, there are two ways to ensure that one’s biological children do not inherit a hereditary condition. The first is to conceive naturally, use prenatal diagnosis to test the fetus […]

Read More…

Does consent make open label placebo research ethical?

By Laura Specker Sullivan Open label placebo studies hypothesize that placebos can be effective even when there is complete transparency about what participants are given. These studies are being run for conditions such as chronic pain, cancer-related fatigue, and irritable bowel syndrome. Open label placebos have garnered significant interest in the popular imagination, perhaps due […]

Read More…

Are children who are born without a cerebral cortex conscious?

By Anna-Karin Margareta Andersson The article highlights an important but surprisingly neglected medical ethical topic: new research suggests that children born without a cerebral cortex are conscious. What types of care should they be provided in order to respect their human rights? This topic caught my attention thanks to Professor Alan Shewmon and colleagues’ pivotal […]

Read More…

Do No Harm in cancer screening programmes: can consent save the day?

By Lotte Elton Screening might harm you. That isn’t what the adverts will tell you. But, increasingly, there is a growing awareness that, for some, cancer screening might lead to unnecessary and potentially harmful investigations and treatments. This seems to violate the ethical principle of non-maleficence: the injunction that doctors ‘do no harm’ to their […]

Read More…

What end of life care do we want to give to persons with end-stage dementia?

By Joseph Dimech, Emmanuel Agius, Julian C Hughes and Paul Bartolo. Dementia is a degenerative neurocognitive disorder that leads to a high level of physical and cognitive disability as the disease progresses to its end-stage. Such patients are also at high risk of suffering from co-morbidities, including aspiration pneumonia secondary to swallowing difficulties. Thus, such […]

Read More…